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Abstract  
Introduction: Hepatitis B virus infection is a major global health problem of public health importance. In a bid to control the infection, the 
Nigerian government in 2004 introduced hepatitis B vaccine into the National Program on Immunization. There are no studies on the prevalence of 
hepatitis B in adolescent prior to 2004.The study was aimed at determining the seroprevalence and predictors of viral Hepatitis B in Nigerian 
children aged 11-19 years. Methods: A cross sectional analytical study was conducted in July 2014.Multi-staged sampling technique was used to 
select 749 children from six secondary schools in Calabar, Cross River State, Nigeria. Ethical clearance was obtained from the Cross River State 
Medical Ethical Committee. A validated structured interviewer administered questionnaire was used to obtain information from participants 
following parental consent. Blood samples were obtained for qualitative detection of HBsAg using rapid chromatographic immunoassays with test 
kits from ABON (China) having sensitivity, specificity and accuracy of >99%, 97% and 98.5% respectively. Data was analyzed using SPSS version 
20.2. Results: Nine of the749 students screened were positive for HBsAg giving an overall prevalence of 1.2%. The sex specific prevalence was 
0.8% for males and 1.8% for females. After multivariate analysis, age was the predictor of hepatitis B infection (OR 3.92; 95% CI 1.22-12.63; p-
value 0.02). Conclusion: The prevalence of HBV infection was low. Despite the low prevalence, the introduction of the vaccine is justifiable in 
view of the public health importance of the infection. 
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Introduction 
 
Hepatitis B viral infection is a major global health problem with 
predilection for the liver and is known to commonly lead to chronic 
infections after the acute infection. The chronic infections increases 
risk of death from childhood hepatic failure, cirrhosis of the liver and 
liver cancer [1-4]. The earliest recognition of the public health 
importance of hepatitis B virus infection is thought to have occurred 
when it appeared as an adverse event associated with a vaccination 
campaign [5,6]. 
  
More than 300 million people have chronic liver infections globally 
and about 600,000 people die annually from acute or chronic 
complications of hepatitis B infection [5]. The highest prevalence of 
hepatitis B infection is in sub-Saharan Africa and East Asia [5]. 
Majority of the people in these regions become infected during 
childhood and between 5–10% of the adult population is chronically 
infected [5]. 
  
Several studies in Nigerian children have recorded prevalence rates 
of hepatitis B surface antigen (HBsAg) ranging from 4.1% to 44.7% 
varying from one locale to another [7-16]. Some of these studies 
however were hospital based with obvious limitations and different 
screening methods were used. The pooled prevalence of HBV in 
Nigeria from studies carried out between 2000 and 2013 is 13.6% 
and for children was 11.5% [17]. HBV prevalence in Nigeria also 
varied by the screening method used; the result varied from 12.3% 
by enzyme-linked immunosorbent assay; 17.5% by 
immunochromatography; and 13.6% by HBV DNA polymerase chain 
reaction [17]. HBV infection is thus hyperendemic in Nigeria and 
may be the highest in sub-saharan Africa [17]. 
  
The seroprevalence of HBsAg among children which serves as a 
proxy for chronic HBV infection is the first indicator that will be 
affected by an infant vaccination programme and can therefore be 
used to monitor the programme’s impact over a short term [1]. A 
vaccine against hepatitis B has been available since 1982 [5,6]. 
Hepatitis B vaccine is 95% effective in preventing infection and its 
chronic consequences; it was the first vaccine against a major 
human cancer [6]. The recombinant vaccines by Pablo DT 
Valenzuela in 1986 replace the earlier vaccine [5]. In Nigeria, the 
vaccine was introduced into the National Program on Immunization 
(NPI) in 2004. It is therefore important to know the prevalence rate 
of HBV infection in each community before introduction of routine 
immunization in children. 
  
This work was therefore designed to determine the seroprevalance 
of Hepatitis B in children who were born before the introduction of 
hepatitis B vaccine into the NPI schedule in Nigeria. It is hoped that 






Study area: the study was conducted in Calabar, the capital city of 
Cross River State, south south geopolitical zone, Nigeria. Calabar 
has two local government areas (LGA); Calabar Municipality and 
Calabar South. The population of Calabar Municipality is 183,681 
while Calabar South is 191,515. There are a total of 20 public 
Secondary Schools (14 in Calabar Municipality and 6 in Calabar 
South) in Calabar.The total student population is 20,993 (12,514 in 
Calabar Municipality and 8,479 in Calabar South). 
  
Study design: the study was a cross sectional analytical study to 
determine the seroprevalence and predictors of viral hepatitis B in 
Secondary school children aged 11-19 years. 
  
Study period: the study was carried out in July 2014. 
  
Study population: the study population consisted of children aged 
11 to 19 years who had not been vaccinated against hepatitis B 
virus. 
  
Ethical approval: ethical approval for the conduct of this study 
was obtained from the Cross River State Health Research Ethics 
Committee. Clearance was also obtained from Cross River State 
Ministry of Education and Ministry of Health. Informed consent was 
obtained from each parent/legal guardian of eligible participants 




Multistage sampling technique was used to recruit subjects for this 
study. This involved five stages. The first stage was by stratified 
random sampling technique based on location of schools into 
Calabar Municipality and Calabar South to select participating 
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students proportionately. Second stage was by simple random 
sampling to select number of participating schools. In the third 
stage, each of the six selected schools was stratified based on 
classes. For each school with six classes (JSS 1, 2, 3, SSS 1, 2 and 
3), one sixth of the sample size for the school was equally allocated 
to each class, for those with classes less than these, the sample size 
was calculated equally among them. 
  
For the fourth stage, each class was stratified based on streams 
(that is A, B, C, etc) in the class. The number of children recruited 
from the class was equally allocated among the streams. 
  
The fifth stage was the final recruitment of a child from a particular 
stream. Serial numbers of students in the class register was used. 
From the class register, participants were selected randomly. This 
ensured that any child in the school could be recruited. Where a 
subject was to be picked by random selection but was not available 
in school for any reason or did not satisfy the inclusion criteria, such 
was dropped and the next was taken. 
  
Data collection: data were collected using a structured interviewer 
administered questionnaire. The following information about the 
participants were obtained; general characteristics (age, sex), family 
socioeconomic status based on Oyedeji’s classification [18] using 
parents/guardian’s occupation and level of education, social history 
of the students( sexual exposures, cigarette smoking), numbers of 
persons in the household, history of jaundice in the household, 




Blood samples were obtained from all eligible subjects for 
serological test for HBsAg antibody. Two millitres (2mL) of venous 
blood was obtained from each participant under aseptic procedure 
into a properly labeled serial number-tagged clean plain bottle and 
allowed to clot. Serum was separated and used for the analysis. 
  
Hepatitis B surface antigen (HBsAg) was detected using 
commercially-available rapid chromatographic immunoassays for the 
qualitative detection of HbsAg manufactured by ABONTM (Abon 
Biopharm (Hangzhou) Co., Ltd #19812th Street East, Hangzhou 
Economic & Technological Development Area, Hangzhou, 310018, 
P.R. China). The qualitative assays were performed using one-step 
test strips for detection of HbsAg in serum samples. Test was 
performed within one hour of specimen collection and separation. 
The immunochromatographic reaction was allowed to take place 
within a few minutes and the result read at exactly 15 minutes 
after. 
  
Only clear, non-haemolyzed serum samples were used. The HBsAg 
assay has manufacturer-reported diagnostic specificity, sensitivity 
and accuracy of >99.0%, 97.0% and 98.5% respectively. The 
results of the test were reported as positive, negative or invalid 
accordingly. For each invalid test, the test procedure was reviewed 




The data obtained was analyzed using statistical package for social 
sciences (SPSS) version 20.2 Inc. Chicago, Illinois -USA. Categorical 
and continuous variables were analyzed using Chi-square and 
Student’s t-test respectively. Binary logistic regression analysis was 
used to control for anticipated confounders. A p-value of 0.05 was 





General characteristics of the study population 
  
A total of 749 children aged between 11 years to 19 years 
participated in the study. Nine of the participants were positive for 
HBsAg giving a seroprevalence of 1.2%. Of these, 477 (63.7%) 
were females and 272 (36.3%) were males giving a ratio of 1.7:1. 
The age group 14 to 16 years had the highest representation with a 
total of 384 (51.8%). The mean age of children studied was 14.8 ± 
2.0. This is as shown in Table 1.Table 2 shows the bivariate 
analysis between variables and outcome of HBsAg screening. Age 
and unsafe traditional practice of scarification mark were statistically 
significant for positivity to HBV. There was an increasing trend in 
the age of participants positive for HBs-antigenaemia, this was 
statistically significant (p = 0.020). Seven out of the nine 
adolescents were of the low socio-economic class. Table 3 shows 
the binary logistic regression model for HBsAg positivity, age was 
the only variable that significantly predicted positivity to HBsAg at 
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Discussion 
 
The seropositivity of HBsAg in this study was 1.2%. This prevalence 
is less than most studies carried out in Nigerian children where the 
prevalence ranged from 4.1% to 44.7% [7-16]. Some of these 
studies were done in a hospital setting and had fewer sample size 
compared to the present study. Ugwuja et al [7] carried out their 
study on adolescent age group in south eastern Nigeria and they 
had a prevalence of 4.1%. Different screening methods were used 
for laboratory analysis, this could have accounted for the differences 
in the prevalence rates [17]. 
  
There was a significant association between increasing age and 
positivity to HBsAg in this study. This is similar to that observed by 
Abiodun et al [10] in Benin City and Bukbuk et al [13] in Maiduguri 
in Nigeria. This also supports the assertion that vertical transmission 
may not play a major role in the spread of HBV infection in Nigeria 
[19,20]. In some West African countries, some reports have shown 
that horizontal transmission may play more role in infection with 
HBV than vertical transmission [21-23]. 
  
In this study, female children had a higher prevalence than their 
male counterparts though the difference did not reach the level of 
significance. Donbraye et al [16] working in Osun state, south west, 
Nigeria also showed higher prevalence in female children than males 
but the difference similarly did not reach significant level. Bukbuk et 
al [13] working in northern Nigeria also showed no significant 
difference between males and females. Other risk factors associated 
with HBV infection in the study population though not statistically 
significant included number of persons in the household, unsafe 
sexual exposure, traditional practice (scarification marks) and low 
socio-economic status of the family. 
  
This is also in agreement with Al- Faleh et al [24] working in Saudi 
Arabia who demonstrated that family size and socio-economic status 
was not significantly associated with HBV positivity in children. 
Chukwuka et al [14] also working in Ebonyi State, Nigeria showed 
no significant association between the cultural practice of 
scarification marks and ear piercing to HBs-antigaenaemia though 







The study shows a low prevalence of asymptomatic HBV infection 
among the participants. Although the prevalence is low, the 
chronicity of the illness and high cost of treatment makes preventive 
strategies a reasonable option in resource-limited countries. Public 
health education and vaccination against the virus are therefore 
advocated for adolescents born in the pre- hepatitis B vaccine era in 
the Nigeria. 
 
What is known about this topic 
 Hepatitis B is a disease of public health importance which 
is endemic in many parts of the world 
 The highest prevalence of hepatitis B infection is in sub-
Saharan Africa and East Asia 
 More than 300 million people have chronic liver infections 
globally and about 600,000 people die annually from 
acute or chronic complications of hepatitis B infection. 
 
What this study adds 
 This study has provided the prevalence of hepatitis B in 
adolescents delivered in the pre-vaccination era in 
Calabar, Cross River State, Nigeria. 
 This study shows that though the prevalence of hepatitis 
B was low in this study population, due to the public 
health importance of the disease the introduction of 
vaccination is justified. 
 Though not statistically significant, unsafe traditional 
practice of scarification mark contributed to those positive 
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Age(years)       
11-13 55(7.4) 149(20.1) 204(27.5) 
14-16 142(19.1) 242(32.6) 384(51.8) 
17-19 72(9.7) 82(11.1) 154(20.8) 
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Table 2: Bivariate analysis between variables and outcome of HBsAg screening 
Variable   
HbsAg result 
Total χ2 (p- value) 
Positive Negative 
Age (years)   7.837(0,020) 
11-13 0(0.0) 204(100.0) 204(100.0)   
14 – 16 4(1.0) 387(99.0) 391(100.0)   
17  - 19                         
    
5(3.2) 149(96.8) 154(100.0)   
Gender Fisher’s exact 
(0.730) 
      0.253(0.615) 
Male 4(1.5) 268(98.5) 272(100.0)   
Female 5(1.0) 472(99.0) 477(100.0)   
Number of persons in 
house 
      0.257(0.879) 
4 1(0.8) 128(99.2) 129(100.0)   
       5- 9 7(1.3) 523(99.2) 530(100.0)   
≥10                           1(1.2) 89(98.8) 90(100.0)   
History of Jaundice in 
Household Member   
      0.579(0.447) 
Yes 0(0.0) 45(100.0) 45(100.0)   
No 9(1.3) 695(98.7) 704(100.0)   
Sexual Exposure       0.984(0.321) 
Yes 1(3.0) 33(97.0) 34(100.0)   
No 8(1.1) 707(98.9) 715(100.0)   
Smoking of Cigarette       0.048(0.826) 
Yes 0(0.0) 4(100.0) 4(100.0)   
No 9(1.2) 736(98.8) 745(100)   
Traditional Practice 
(Scarification mark) 
      4.082(0.043) 
Yes 3(3.4) 86(96.6) 89(100.0)   
No 6(0.9) 654(99.1) 660(100.0)   
Socioeconomic status 
of parents 
      
Fisher’s Exact 
(0.28) 
Low 4(0.9) 425(99.1) 429(100.0)   
Middle 2(1.0) 196(99.0) 198(100.0)   
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Table 3: Binary logistic regression model of factors that influence seroprevalence of viral hepatitis B 
Variables Odds Ratio 95% CI p-value 
Age       
< 14 3.92 1.22 – 12.63 0.02 
≥14 1     
Gender       
Female 1     
Male 1.05 0.27 – 4.08 0.95 
Number of persons in the household       
≤14 1.07 0.30 – 3.85 0.92 
>14 1     
History of jaundice in the household       
No 1     
Yes 2.70 0.0 1.0 
Sexual exposures       
No 1     
Yes 1.41 0.16 – 12.34 0.76 
Traditional practices (scarification 
marks) 
      
No 1     
Yes 3.14 0.74-13.38 0.12 
Smoking of cigarettes       
Yes 0.00 0.00 1.0 
No 1     
Parents socioeconomic status       
Low 0.00 0.00 0.99 
Medium/high 1     
  
 
 
